BioAtla Investor
BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2007-01-01
Employees Number:
51-100
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Register and Claim Ownership